BETAMETHASONE DIPROPIONATE

N/A

18,714 FDA adverse event reports analyzed

Last updated: 2026-04-15

About BETAMETHASONE DIPROPIONATE

BETAMETHASONE DIPROPIONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS). The most commonly reported adverse reactions for BETAMETHASONE DIPROPIONATE include DRUG INEFFECTIVE, OFF LABEL USE, MACULAR DEGENERATION, NAUSEA, PSORIASIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BETAMETHASONE DIPROPIONATE.

Top Adverse Reactions

DRUG INEFFECTIVE1,341 reports
OFF LABEL USE540 reports
MACULAR DEGENERATION522 reports
NAUSEA483 reports
PSORIASIS471 reports
PAIN413 reports
PRURITUS394 reports
PAIN IN EXTREMITY368 reports
FATIGUE365 reports
CONDITION AGGRAVATED361 reports
RASH351 reports
HEADACHE330 reports
DYSPNOEA316 reports
DIARRHOEA303 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE303 reports
PRODUCT USE IN UNAPPROVED INDICATION295 reports
MALAISE274 reports
PNEUMONIA265 reports
WEIGHT DECREASED256 reports
PYREXIA255 reports
ERYTHEMA243 reports
VOMITING232 reports
ANXIETY224 reports
ARTHRALGIA218 reports
ABDOMINAL PAIN205 reports
CONSTIPATION201 reports
HYPERSENSITIVITY189 reports
URTICARIA186 reports
ASTHMA183 reports
ANAEMIA178 reports
HYPERTENSION178 reports
DIZZINESS176 reports
DYSPEPSIA164 reports
MUSCLE SPASMS161 reports
SKIN EXFOLIATION157 reports
STOMATITIS155 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION150 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION148 reports
PSORIATIC ARTHROPATHY148 reports
PULMONARY EMBOLISM147 reports
DRUG ERUPTION142 reports
WHEEZING142 reports
HEPATIC FUNCTION ABNORMAL141 reports
LUNG DISORDER141 reports
THROMBOSIS141 reports
PRODUCT DOSE OMISSION ISSUE140 reports
INCORRECT ROUTE OF PRODUCT ADMINISTRATION138 reports
BACK PAIN137 reports
ASTHENIA136 reports
SLEEP DISORDER134 reports
DEATH132 reports
SEPSIS132 reports
DRY SKIN131 reports
EPISTAXIS131 reports
PERIPHERAL SWELLING130 reports
INSOMNIA126 reports
DERMATITIS ATOPIC125 reports
INFUSION RELATED REACTION124 reports
ECZEMA123 reports
CONTUSION122 reports
FALL122 reports
HYPOTHYROIDISM118 reports
PULMONARY FIBROSIS118 reports
RESPIRATORY SYMPTOM116 reports
DRUG HYPERSENSITIVITY114 reports
INJECTION SITE PAIN113 reports
COUGH112 reports
ABDOMINAL DISCOMFORT111 reports
PROCEDURAL PAIN111 reports
CHRONIC SINUSITIS110 reports
FULL BLOOD COUNT ABNORMAL110 reports
HAEMOPTYSIS110 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES108 reports
WEIGHT INCREASED108 reports
NASOPHARYNGITIS107 reports
COLITIS ULCERATIVE106 reports
HAEMATOCHEZIA106 reports
OBSTRUCTIVE AIRWAYS DISORDER106 reports
PARAESTHESIA ORAL106 reports
SOMNOLENCE106 reports
PULMONARY ALVEOLAR HAEMORRHAGE104 reports
STRESS104 reports
VASCULITIS103 reports
PRODUCT USE ISSUE102 reports
PULMONARY VASCULITIS102 reports
ALOPECIA101 reports
GENERAL PHYSICAL HEALTH DETERIORATION101 reports
NEURITIS101 reports
NEUROLOGICAL SYMPTOM101 reports
RECTAL HAEMORRHAGE101 reports
COLITIS99 reports
HYPOXIA98 reports
OEDEMA PERIPHERAL98 reports
DRUG INTOLERANCE96 reports
ORAL CANDIDIASIS96 reports
CHEST PAIN95 reports
FEELING ABNORMAL95 reports
SWELLING95 reports
HYPOAESTHESIA94 reports
DEPRESSION93 reports

Report Outcomes

Out of 5,833 classified reports for BETAMETHASONE DIPROPIONATE:

Serious 68.1%Non-Serious 31.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Age

Age 65173 reports
Age 34142 reports
Age 71124 reports
Age 80114 reports
Age 54102 reports
Age 6499 reports
Age 5990 reports
Age 4388 reports
Age 6388 reports
Age 6687 reports
Age 7286 reports
Age 7880 reports
Age 5879 reports
Age 6878 reports
Age 7075 reports
Age 5373 reports
Age 6068 reports
Age 6968 reports
Age 5767 reports
Age 7467 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with BETAMETHASONE DIPROPIONATE?

This profile reflects 18,714 FDA FAERS reports that mention BETAMETHASONE DIPROPIONATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for BETAMETHASONE DIPROPIONATE?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, OFF LABEL USE, MACULAR DEGENERATION, NAUSEA, PSORIASIS, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.